Abiopharma

New Form DEL AM - 60 DEGREES PHARMACEUTICALS, INC. <b>Filed:</b> 2026-08-17 <b>AccNo:</b> 0001213900-26-090587 <b>Size:</b> 6 KB

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-08-17 <b>AccNo:</b> 0001918704-26-023869 <b>Size:</b> 682 KB

Intelligent Bio Solutions Inc. - Intelligent Bio Solutions Strengthens Quality Management Credentials with ISO Recertification

20/20 BioLabs Reports Second Quarter 2026 Financial Results and Recent Operational Progress, as Cancer Test Revenue Reaches Record Quarterly Level

Director Andorn Karni Yarl 🟡 adjusted position in 5.5K shares (2 derivative) of CAMTEK LTD (CAMT) at $172.74 ($1.2M) Transaction Date: Aug 13, 2026 | Filing ID: 000745

New Form 424B2 - BANK OF NOVA SCOTIA <b>Filed:</b> 2026-08-17 <b>AccNo:</b> 0001839882-26-040147 <b>Size:</b> 421 KB

(99% Neutral) DERMATA THERAPEUTICS, INC. (DRMA) Announces Business Combination

(99% Neutral) ABUNDIA GLOBAL IMPACT GROUP, INC. (AGIG) Announces Business Combination

Profound’s Introduction of New Real-time Interventional MRI Software Paving the Way for Full‘TULSA Days’

Clene to Present at the Emerging Growth Conference

(99% Neutral) HANMI FINANCIAL CORP (HAFC) Announces Business Combination

Director BALBIRNIE BRIAN R 🟢 acquired 10.0K shares of ACCESS Newswire Inc. (ACCS) at $4.95 Transaction Date: Aug 14, 2026 | Filing ID: 006517

Dermata Therapeutics Announces $3.4 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Director Bond Ryan 🟢 acquired 21.1K shares of Aclarion, Inc. (ACON) at $2.37 Transaction Date: Aug 13, 2026 | Filing ID: 006516

Director Pollard Wesley T 🟢 acquired 2.0K shares of ACCESS Newswire Inc. (ACCS) at $4.99 Transaction Date: Aug 14, 2026 | Filing ID: 006515